Sun
—
Asia/Singapore
—

WRLD A.LIVE

SingaporeTopics

Topic — Parkinson’s disease research

23 reports · the last 24 hours · Asia/Singapore

← All topics · now
Right now

A phase 3 Parkinson’s drug trial has met its main goal.

23 reports · the last 24 hours

Summary · from headlines6 points
  • Studies found microglia can protect vulnerable dopamine neurons by removing toxic α-synuclein aggregates.
  • Studies linked greater physical activity with slower Parkinson’s progression and long-term cognitive and motor benefits.
  • A first single-cell DNA analysis revealed mitochondrial damage in vulnerable Parkinson’s brainstem neurons.
  • A report found Parkinson’s traits vary by sex, from motor issues to smell loss.
  • Solengepras met the primary endpoint in the Phase 3 ARISE trial of Parkinson disease.
  • Dundee researchers are bringing a pioneering Parkinson’s trial to local patients.
Latest developments6 to read first

Timeline 23 reports

9 Oct 20264 reportsToday

01:004 reports

8 Oct 202619 reports

23:001 report

22:00nothing heard

21:001 report

20:00nothing heard

19:001 report

18:001 report

17:003 reports

16:00nothing heard

15:00nothing heard

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:00nothing heard

09:00nothing heard

08:00nothing heard

07:00nothing heard

06:00nothing heard

05:001 report

04:006 reports

03:005 reports

Topics in view—

Daylight computed from the real position of the sun over Singapore · Area outlines and places contain information from URA Master Plan 2025 Planning Area Boundary (No Sea), accessed 29 Sep 2026 from data.gov.sg, made available under the Singapore Open Data Licence v1.0 ·